ONCAlert | Upfront Therapy for mRCC
Videos
Rationale for Phase I Study of AMG 330 in Relapsed/Refractory AML
2:30 PM, Mon December 10, 2018
Advice for Treating Patients With Lung Cancer
6:57 PM, Fri December 7, 2018
Challenge in Treating Patients With Multiple Myeloma
4:17 PM, Thu December 6, 2018
Findings From the RELEVANCE Trial in Follicular Lymphoma
2:55 PM, Wed November 28, 2018
Selecting Cytoreductive Therapy for Patients with PV or ET
2:52 PM, Wed November 28, 2018
Safety Data From the Phase II JULIET Trial in DLBCL
2:50 PM, Wed November 28, 2018
Selecting I-O Agents and Combinations for Patients With RCC
3:25 PM, Tue November 27, 2018
Rationale for Combination Therapy in Multiple Myeloma
6:51 PM, Tue November 20, 2018
